Incidence of composite of all death, MI and stroke (defined as MACCE) 12-33 months post-stent [clinicaltrials_resource:73e87242b0d6eb4c7414ba29846e3013]
placebo for clopidogrel + aspirin OR placebo for prasugrel + aspirin
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Incidence of composite of all death, MI and stroke (defined as MACCE) 12-33 months post-stent [clinicaltrials_resource:73e87242b0d6eb4c7414ba29846e3013]
placebo for clopidogrel + aspirin OR placebo for prasugrel + aspirin
Bio2RDF identifier
73e87242b0d6eb4c7414ba29846e3013
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:73e87242b0d6eb4c7414ba29846e3013
measure [clinicaltrials_vocabulary:measure]
Incidence of composite of all death, MI and stroke (defined as MACCE)
time frame [clinicaltrials_vocabulary:time-frame]
12-33 months post-stent
description
placebo for clopidogrel + aspirin OR placebo for prasugrel + aspirin
identifier
clinicaltrials_resource:73e87242b0d6eb4c7414ba29846e3013
title
Incidence of composite of all ...... MACCE) 12-33 months post-stent
@en
type
label
Incidence of composite of all ...... 87242b0d6eb4c7414ba29846e3013]
@en